Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

RAPT Therapeutics, Inc. Director's Dealing 2025

Jul 1, 2025

32942_dirs_2025-06-30_16dfb87a-bef4-4342-83c4-22e372c2f4d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RAPT Therapeutics, Inc. (RAPT)
CIK: 0001673772
Period of Report: 2025-06-21

Reporting Person: Dombkowski Ashley L. (N/A)

More from RAPT Therapeutics, Inc.

Regulatory Filings 2026
Mar 18
Regulatory Filings 2026
Mar 3
Major Shareholding Notification 2026
Feb 17
Major Shareholding Notification 2026
Feb 13
Major Shareholding Notification 2026
Feb 9
Director's Dealing 2026
Feb 2
Director's Dealing 2026
Feb 2
Director's Dealing 2026
Feb 2
Director's Dealing 2026
Feb 2
Regulatory Filings 2026
Feb 2
View all filings →